Our People

Choose a member of GMANN to view their Bio

Muir Morton


Locum Renal Consultant


MA Hons, MbbS, MRCP, MRCP Neph, PhD

Special interests

Kidney transplantation, infective and malignant complications of immunosuppression, EBV infection and PTLD, recurrent disease.

Brief biography

I trained in medicine at the University of Manchester after completing an initial degree in History MA (Hons) at Edinburgh (Essential training for any nephrologist). I graduated in 2002 and trained as a junior doctor on the South Manchester University Hospitals medical rotation. I was appointed SpR in Renal Medicine after obtaining my MRCP in 2006. I was then appointed to an Astellas Transplant Clinical Fellow post in 2008 providing a year-long subspecialty training in transplantation at Manchester Royal. From 2009-2012 I completed a period of research with the University of Manchester resulting in the award of my PhD in 2013. The research included leading a prospective observational study that recruited 500 patients, investigating Epstein-Barr virus infection after transplantation, with a focus on the most serious consequence of infection - Post-Transplant lymphoproliferative Disorder (PTLD). I have been the lead investigator for three successful applications for research grants and have been involved in collaborative research with the Christie Hospital. More recently I have been a member of a national working group identifying and developing national multi-centre clinical trials and research priorities in relation to kidney transplantation.

Recent Publications

  1. Morton M, Coupes B, Roberts SA, Klapper PE, Byers RJ, Vallely PJ, Ryan K, Picton ML. Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients. Transplantation. 2013 Feb 15;95(3):470-8.
  2. Morton M, Edmonds S, Doherty AM, Dhaygude A, Helbert M, Venning M. Factors associated with major infections in patients with granulomatosis with polyangiitis and systemic lupus erythematosus treated for deep organ involvement. Rheumatol Int. 2012 Nov;32(11):3373-82.